Open AccessHigh E-Selectin Ligand Expression Contributes to Chemotherapy-Resistance in Poor Risk Relapsed and Refractory (R/R) Acute Myeloid Leukemia (AML) Patients and Can be Overcome with the Addition of Uproleselan
Author(s) -
Daniel J. DeAngelo,
Brian A. Jonas,
Jane L. Liesveld,
Dale L. Bixby,
Anjali S. Advani,
Paula Marlton,
Michael O’Dwyer,
William E. Fogler,
John L. Magnani,
Mary M Chen,
Eric J. Feldman,
Helen Thackray,
Pamela S. Becker
Publication year - 2019
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood-2019-123744
Subject(s) - bone marrow , cytarabine , leukemia , myeloid leukemia , medicine , chemotherapy , cancer research , immunology , etoposide , population , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom